Alcohol Withdrawal Delirium: Clinical Trials

11 trials for Alcohol Withdrawal Delirium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 terminated, 1 not yet recruiting, 1 unknown. 4 Not applicable, 3 Phase 4, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 2, Not yet recruiting 1, Terminated 1
Phase 43Completed 1, Terminated 1, Unknown 1
Phase 11Completed 1
Phase 31Completed 1

Follow Alcohol Withdrawal Delirium: new trials by email Literature Review of Alcohol Withdrawal Delirium trials Research Report on Alcohol Withdrawal Delirium

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preventox - a Digital Intervention for Patients With Intoxications in Intensive Care
Preventox, a digital self-help tool for patients with intoxications in intensive care., Preventox control group - Intoxication, Delirium Tremens (DTs)
Not applicableNot yet recruitingKarolinska Institutet502026-09-302026-09-23
Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome
Phenobarbital Sodium, Inactive placebo - Alcohol Withdrawal Delirium, Alcohol Withdrawal
Not applicableTerminatedUnity Health Toronto82021-06-112023-11-02
Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit
Phenobarbital, Lorazepam - Alcohol Withdrawal, Alcohol Withdrawal Delirium
Phase 4UnknownOSF Healthcare System1422020-07-062020-10-08
Treatment Of Alcohol Withdrawal Syndrome: Dexmedetomidine Vs Diazepam In A Hospital O'horán
Dexmedetomidine 0.004 MG/ML, Diazepam Injectable Solution - Alcohol Withdrawal Delirium
Phase 4CompletedCentro Medico Nacional La Raza, IMSS22017-11-012019-03-15
Baclofen to Prevent Agitation in Alcohol Addicted Patients in ICU
BACLOFEN, PLACEBO - Alcoholism
Phase 3CompletedNantes University Hospital3142016-06-272026-09-14
Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder
oxytocin, placebo - Alcoholism, Alcohol Related Disorders
Phase 1CompletedJohns Hopkins University272015-03-012017-12-04
Hyperbaric Oxygenation in Treatment of Alcohol Dependence Syndrome
Hyperbaric Oxygenation Therapy, Normobaric Oxygenation therapy - Alcohol Withdrawal Symptoms, Delirium Tremens (DTs)
Not applicableCompletedJubilee Mission Medical College and Research Institute302014-11-012018-03-19
Treatment of Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or Anticonvulsants
BZDP-Sparing Protocol, BZDP-Based Protocol - Alcohol Withdrawal Syndrome
CompletedStanford University302013-08-012022-06-30
The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS)
Alcohol Withdrawal Syndrome
CompletedStanford University4092012-05-012015-01-30
Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)
Dexmedetomidine, Placebos - Alcohol Withdrawal Delirium, Alcohol Withdrawal Associated Autonomic Hyperactivity
Phase 4TerminatedDenver Health and Hospital Authority492012-03-012017-11-06
Treating Alcohol Withdrawal With Oral Baclofen
Baclofen, Placebo, Lorazepam - Alcohol Withdrawal Delirium
Not applicableCompletedEssentia Health792003-04-012011-07-27

Narrower conditions

Alcoholism (4)  ·  Alcohol Withdrawal Seizures (3)  ·  Alcohol-Related Disorders (1)  ·  Psychomotor Agitation (1)  ·  Tremor (1)

Broader conditions

Alcohol-Induced Disorders (11)  ·  Alcohol-Induced Disorders, Nervous System (11)  ·  Chemically-Induced Disorders (11)  ·  Mental Disorders (11)  ·  Nervous System Diseases (11)  ·  Neurotoxicity Syndromes (11)  ·  Poisoning (11)  ·  Substance Withdrawal Syndrome (11)  ·  Substance-Related Disorders (11)  ·  Alcohol-Related Disorders (10)  ·  Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Seizures (3)  ·  Dyskinesias (2)

Interventions

Baclofen (2)  ·  Dexmedetomidine (2)  ·  Lorazepam (2)  ·  Phenobarbital (2)  ·  Benzyl Alcohols (1)  ·  Critical Care (1)  ·  Diazepam (1)  ·  Hyperbaric Oxygenation (1)  ·  Oxytocin (1)

Sponsors

Stanford University (2)  ·  Centro Medico Nacional La Raza, IMSS (1)  ·  Denver Health and Hospital Authority (1)  ·  Essentia Health (1)  ·  Johns Hopkins University (1)  ·  Jubilee Mission Medical College and Research Institute (1)  ·  Karolinska Institutet (1)  ·  Nantes University Hospital (1)  ·  OSF Healthcare System (1)  ·  Unity Health Toronto (1)

Countries

United States (6)  ·  Canada (1)  ·  France (1)  ·  Mexico (1)

Top investigators

Bhagat Aulakh, MD (1)  ·  Elise Weerts, Ph.D. (1)  ·  Ivor S Douglas, MD, FRCP (1)  ·  Jeffrey Lyon, MD (1)  ·  Jose Maldonado, MD (1)  ·  Jose R Maldonado, MD (1)  ·  Karen Burns (1)

Results publications

PMID 20944765, PMID 20951277, PMID 22898443, PMID 24657098, PMID 27542731, PMID 33423824, PMID 33620407, PMID 35065662, PMID 8701843

NIH funding

2025 (1)